He has conquered Covid for the time being, and now the CEO of BioNTech says he wants to turn his attention back to his first interest: cancer.
Dr. Ugur Sahin is trying out the same mRNA technology that underlies the Covid-19 vaccine that BioNTech brought to much of the world -- along with its partner Pfizer -- to try to improve the newest and riskiest approach to treating cancer: CAR-T therapy.'use strict';CNN.Videx=CNN.Videx || {};CNN.Videx.mobile={};CNN.INJECTOR.executeFeature.then {CNN.VideoPlayer.
BioNTech CEO tells CNN when US could see impact from vaccine 02:54Sahin hopes to use a type of mRNA vaccine to improve the treatment, making it both safer and more effective -- and perhaps making it cheaper in the long run. He's presenting some very early results from clinical trials at the Society for Immunotherapy of Cancer meeting in Washington, DC."We are cancer doctors," Sahin told CNN in an interview ahead of the meeting."We are really passionate about that.
He declines to estimate how he could make a $400,000 treatment affordable for the world.Instead, he speaks of"optimizing the process." At first, he notes, messenger RNA was hard to produce and extremely expensive. BioNTech figured out how to make it cheaply and abundantly for use in a vaccine that's now being produced by the billions."If there is no next, best product, then you have a product," he said.
Evil empire
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WSJ - 🏆 98. / 63 Read more »